Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
Preprint in English | medRxiv | ID: ppmedrxiv-20037689

ABSTRACT

Italy became the second epicenter of the novel coronavirus disease 2019 (COVID-19) pandemic after China, surpassing by far Chinas death toll. The disease swept through Lombardy, which remained in lockdown for about two months, starting from the 8th of March. As of that day, the isolation measures taken in Lombardy were extended to the entire country. Here, assuming that effectively there was one case "zero" that introduced the virus to the region, we provide estimates for: (a) the DAY-ZERO of the outbreak in Lombardy, Italy; (b) the actual number of asymptomatic infected cases in the total population until March 8; (c) the basic reproduction number (R0) based on the estimation of the actual number of infected cases. To demonstrate the efficiency of the model and approach, we also provide a tentative forecast two months ahead of time, i.e. until May 4, the date on which relaxation of the measures commenced, on the basis of the COVID-19 Community Mobility Reports released by Google on March 29. MethodsTo deal with the uncertainty in the number of actual asymptomatic infected cases in the total population, we address a modified compartmental Susceptible/ Exposed/ Infectious Asymptomatic/ Infected Symptomatic/ Recovered/ Dead (SEIIRD) model with two compartments of infectious persons: one modelling the cases in the population that are asymptomatic or experience very mild symptoms and another modelling the infected cases with mild to severe symptoms. The parameters of the model corresponding to the recovery period, the time from the onset of symptoms to death and the time from exposure to the time that an individual starts to be infectious, have been set as reported from clinical studies on COVID-19. For the estimation of the DAY-ZERO of the outbreak in Lombardy, as well as of the "effective" per-day transmission rate for which no clinical data are available, we have used the proposed SEIIRD simulator to fit the numbers of new daily cases from February 21 to the 8th of March. This was accomplished by solving a mixed-integer optimization problem. Based on the computed parameters, we also provide an estimation of the basic reproduction number R0. To examine the efficiency of the model and approach, we ran the simulator to "forecast" the epidemic two months ahead of time, i.e. from March 8 to May 4. For this purpose, we considered the reduction in mobility in Lombardy as released on March 29 by Google COVID-19 Community Mobility Reports, and the effects of social distancing and of the draconian measures taken by the government on March 20 and March 21, 2020. ResultsBased on the proposed methodological procedure, we estimated that the expected DAY-ZERO was January 14 (min-max rage: January 5 to January 23, interquartile range: January 11 to January 18). The actual cumulative number of asymptomatic infected cases in the total population in Lombardy on March 8 was of the order of 15 times the confirmed cumulative number of infected cases, while the expected value of the basic reproduction number R0 was found to be 4.53 (min-max range: 4.40-4.65). The model approximated adequately two months ahead of time the evolution of reported cases until May 4, the day on which the phase I of the relaxation of measures was implemented over all of Italy.

2.
Immunol Lett ; 159(1-2): 23-9, 2014.
Article in English | MEDLINE | ID: mdl-24440200

ABSTRACT

Although several components of the microbial wall of gram-positive bacteria and fungi possess immunostimulatory properties, their pathogenetic role remains incompletely evaluated. The purpose of this study was to assess the basic immune status of patients susceptible to infections and their capability for cytokine production after stimulation with wall components of gram-positive bacteria and fungi. We measured serum cytokine levels as well as cytokine production after ex vivo lipoteichoic acid (LTA) and mannan stimulation of whole blood. The blood was taken from 10 healthy volunteers, 10 patients with end-stage renal disease (ESRD), 10 patients with diabetes mellitus (DM), and 10 patients on their 2nd day of stay in the Intensive Care Unit (ICU), who suffered from non septic systemic inflammatory response syndrome (SIRS) and had an APACHE II score ≥25. We used 1 µg/ml LTA and 100 µg/ml mannan for an incubation period of 8 h to stimulate 100 µl aliquots of whole blood. All patient groups had higher baseline values of TNF-α, IL-6, IL-1ß, and IL-10 compared to the control group, but only for ICU patients the difference was statistically significant. The ratio IL-10/IL-6 was found 0.33, 0.22, and 0.96 in healthy persons, ESRD, and DM patients respectively, and 1.32 in ICU patients. In all examined groups, the levels of cytokines significantly increased after stimulation by LTA and mannan, although in severely ill patients this change was considerably smaller, possibly reflecting a state of monocytes' depression and relative hyporesponsiveness. No significant differences between the LTA and the mannan stimulation were observed.


Subject(s)
Blood Cells/drug effects , Diabetes Mellitus, Type 2/immunology , Kidney Failure, Chronic/immunology , Lipopolysaccharides/pharmacology , Mannans/pharmacology , Systemic Inflammatory Response Syndrome/immunology , Teichoic Acids/pharmacology , Adult , Aged , Blood Cells/immunology , Blood Cells/pathology , Cell Wall/chemistry , Cells, Cultured , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/pathology , Female , Fungi/chemistry , Gram-Positive Bacteria/chemistry , Humans , Intensive Care Units , Interleukin-10/biosynthesis , Interleukin-6/biosynthesis , Kidney Failure, Chronic/diagnosis , Kidney Failure, Chronic/pathology , Lipopolysaccharides/isolation & purification , Male , Mannans/isolation & purification , Middle Aged , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/pathology , Teichoic Acids/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...